Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better?
Somedeb BallAkriti G JainLuis E AguirreNajla Al AliYumeng ZhangOnyee ChanAndrew T KuykendallKendra L SweetJeffrey E LancetDavid M SwobodaEric PadronRami S KomrokjiDavid A SallmanPublished in: American journal of hematology (2022)